For women with excessive menstrual blood loss, the contraceptive levonorgestrel 52 mg delivered via an intrauterine device (IUD) reduced monthly blood loss.
The FDA advisory panel meeting was held to address proposed changes to the iPLEDGE REMS to minimize burden on patients, prescribers, and pharmacies while maintaining safe use of isotretinoin.
A randomized study of expulsion rates reports the risk for expulsion at 2-4 weeks and 6-8 weeks may help patients and clinicians make informed choices about the timing of IUD insertion.
Medicare covers people with disabilities who are young enough to get pregnant. Often, these patients birth control is not covered, and they opt for hysterectomies or tubal ligations, which may be covered.